Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Kern

Concepts (293)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
26
2025
2662
2.300
 Why?
Neuregulin-1
9
2019
49
2.220
 Why?
Carcinoma, Non-Small-Cell Lung
18
2025
1188
1.670
 Why?
Lung
13
2019
4101
1.350
 Why?
Signal Transduction
10
2019
5208
1.030
 Why?
Respiratory Mucosa
4
2014
322
0.970
 Why?
Radiosurgery
3
2025
399
0.930
 Why?
Pneumonectomy
2
2025
167
0.920
 Why?
Antineoplastic Agents, Immunological
3
2022
198
0.850
 Why?
Acute Lung Injury
3
2012
305
0.820
 Why?
ErbB Receptors
7
2014
635
0.720
 Why?
Receptor, ErbB-3
6
2007
48
0.640
 Why?
Protein-Tyrosine Kinases
2
2019
431
0.630
 Why?
Epithelium
2
2019
310
0.620
 Why?
Adult Stem Cells
1
2019
40
0.590
 Why?
Small Cell Lung Carcinoma
1
2020
121
0.560
 Why?
Alveolar Epithelial Cells
1
2019
120
0.560
 Why?
Neuroendocrine Cells
2
2016
33
0.550
 Why?
Adenocarcinoma
5
2019
920
0.540
 Why?
Neoplasm Staging
9
2025
1467
0.520
 Why?
Cell Transformation, Neoplastic
1
2019
337
0.510
 Why?
Immunotherapy
2
2022
665
0.500
 Why?
Neoplasm Proteins
1
2019
441
0.480
 Why?
Tomography, X-Ray Computed
7
2015
2767
0.470
 Why?
STAT3 Transcription Factor
5
2009
206
0.440
 Why?
Interleukin-6
1
2019
775
0.430
 Why?
Adherens Junctions
1
2014
24
0.430
 Why?
B-Lymphocyte Subsets
1
2014
76
0.400
 Why?
Immunity, Humoral
1
2014
118
0.380
 Why?
Cell Adhesion
1
2014
451
0.380
 Why?
Carcinoma, Squamous Cell
4
2019
640
0.370
 Why?
beta Catenin
1
2014
254
0.360
 Why?
Pulmonary Fibrosis
2
2007
395
0.360
 Why?
Epithelial Cells
3
2011
1127
0.360
 Why?
Protein C
1
2012
54
0.360
 Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2012
20
0.360
 Why?
Blood Coagulation Factors
1
2012
71
0.340
 Why?
Quality of Life
1
2024
3194
0.340
 Why?
Smad3 Protein
1
2011
42
0.340
 Why?
Smad2 Protein
1
2011
37
0.340
 Why?
Trans-Activators
2
2004
396
0.330
 Why?
Receptors, Cell Surface
1
2012
372
0.310
 Why?
p38 Mitogen-Activated Protein Kinases
1
2011
264
0.310
 Why?
Transforming Growth Factor beta1
1
2011
176
0.310
 Why?
Bronchoalveolar Lavage Fluid
1
2012
638
0.300
 Why?
Neoplasms
3
2024
2900
0.290
 Why?
Epithelial-Mesenchymal Transition
1
2011
219
0.290
 Why?
Lung Diseases
2
2016
780
0.290
 Why?
Permeability
4
2014
169
0.280
 Why?
Humans
47
2025
145140
0.280
 Why?
Quinazolines
5
2014
266
0.280
 Why?
Phosphorylation
6
2019
1706
0.280
 Why?
Prenylation
1
2008
3
0.270
 Why?
Early Detection of Cancer
1
2013
482
0.270
 Why?
Antibodies, Monoclonal
5
2007
1505
0.260
 Why?
Piperidines
1
2008
220
0.240
 Why?
Tomography, Emission-Computed
2
2003
71
0.230
 Why?
DNA-Binding Proteins
2
2004
1479
0.230
 Why?
Protein Kinase Inhibitors
4
2014
979
0.230
 Why?
Epidermal Growth Factor
3
2012
161
0.220
 Why?
Drug Eruptions
2
2024
28
0.210
 Why?
Autocrine Communication
1
2004
38
0.200
 Why?
Thoracic Surgery, Video-Assisted
1
2024
51
0.200
 Why?
Morphogenesis
1
2004
172
0.200
 Why?
Enzyme Inhibitors
2
2004
820
0.200
 Why?
Pyridines
1
2008
608
0.190
 Why?
Mediastinal Neoplasms
1
2003
53
0.190
 Why?
Skin Diseases
2
2024
152
0.190
 Why?
Mass Screening
1
2012
1354
0.190
 Why?
Aged, 80 and over
9
2025
8318
0.190
 Why?
Genetic Therapy
1
2005
315
0.190
 Why?
Cell Line, Tumor
6
2019
3539
0.190
 Why?
Milk Proteins
1
2002
33
0.180
 Why?
Phosphatidylinositol 3-Kinases
1
2004
382
0.180
 Why?
Clinical Decision-Making
1
2025
362
0.180
 Why?
Cell Line
4
2014
2821
0.180
 Why?
Cisplatin
2
2020
344
0.170
 Why?
ADAM17 Protein
2
2012
42
0.170
 Why?
Cell Proliferation
4
2015
2504
0.170
 Why?
ADAM Proteins
2
2012
64
0.170
 Why?
Fluorodeoxyglucose F18
1
2002
161
0.170
 Why?
Radiopharmaceuticals
1
2002
205
0.170
 Why?
RNA Interference
2
2014
474
0.170
 Why?
Animals
10
2021
37952
0.160
 Why?
CTLA-4 Antigen
1
2021
105
0.160
 Why?
Recombinant Proteins
3
2011
1368
0.160
 Why?
Etoposide
1
2020
167
0.150
 Why?
Female
16
2025
78636
0.150
 Why?
Enzyme Induction
1
2019
88
0.150
 Why?
RNA, Neoplasm
1
2019
83
0.150
 Why?
Tight Junctions
2
2014
82
0.150
 Why?
Antigens
1
2021
348
0.150
 Why?
Receptors, Interleukin-6
1
2019
47
0.140
 Why?
Cells, Cultured
3
2019
4142
0.140
 Why?
Programmed Cell Death 1 Receptor
1
2021
264
0.140
 Why?
Enzyme Activation
2
2014
762
0.140
 Why?
B7-H1 Antigen
1
2021
243
0.140
 Why?
Sirolimus
1
2020
280
0.140
 Why?
Transfection
3
2011
926
0.140
 Why?
Decision Making
1
2025
974
0.140
 Why?
Male
15
2025
72664
0.130
 Why?
Hyperplasia
2
2016
177
0.130
 Why?
Middle Aged
10
2025
36126
0.130
 Why?
Cell Lineage
1
2019
377
0.130
 Why?
Aged
9
2025
26096
0.130
 Why?
Mice
6
2019
18303
0.130
 Why?
Xenograft Model Antitumor Assays
1
2020
932
0.130
 Why?
RNA, Messenger
3
2019
2803
0.120
 Why?
TOR Serine-Threonine Kinases
1
2020
454
0.120
 Why?
Immunosuppressive Agents
1
2021
837
0.120
 Why?
Cytokines
1
2024
2048
0.120
 Why?
Antigen Presentation
1
2017
207
0.120
 Why?
Longitudinal Studies
1
2024
2949
0.120
 Why?
Lymphocytes, Tumor-Infiltrating
1
2017
153
0.120
 Why?
Lung Diseases, Obstructive
1
2016
43
0.120
 Why?
Tumor Cells, Cultured
4
2013
886
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2013
977
0.110
 Why?
Research Report
1
2016
86
0.110
 Why?
Neoplastic Stem Cells
1
2019
409
0.110
 Why?
Mutation
4
2014
4071
0.110
 Why?
Treatment Outcome
4
2024
11741
0.110
 Why?
Drug Synergism
2
2008
354
0.110
 Why?
Multiple Pulmonary Nodules
1
2015
23
0.110
 Why?
Bleomycin
2
2007
255
0.110
 Why?
Electric Impedance
1
2014
108
0.100
 Why?
ral GTP-Binding Proteins
1
2013
5
0.100
 Why?
Bronchiolitis
1
2015
87
0.100
 Why?
Tyrphostins
2
2004
18
0.100
 Why?
Forced Expiratory Volume
1
2015
450
0.100
 Why?
Transcriptome
1
2019
1029
0.090
 Why?
Protein Binding
1
2019
2235
0.090
 Why?
ras Proteins
1
2013
150
0.090
 Why?
Medical Oncology
1
2016
338
0.090
 Why?
Blotting, Western
3
2013
1177
0.090
 Why?
T-Lymphocytes
1
2021
1993
0.090
 Why?
Radiography, Thoracic
1
2013
172
0.090
 Why?
Time Factors
3
2011
7107
0.090
 Why?
RNA, Small Interfering
1
2014
634
0.090
 Why?
History, 20th Century
1
2013
327
0.090
 Why?
B-Lymphocytes
1
2017
866
0.090
 Why?
Tomography, Spiral Computed
1
2011
30
0.090
 Why?
Prognosis
6
2025
4310
0.090
 Why?
Cell Division
2
2004
753
0.090
 Why?
Cell Shape
1
2011
56
0.080
 Why?
Biopsy, Needle
1
2011
185
0.080
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2012
161
0.080
 Why?
Blood-Air Barrier
1
2011
11
0.080
 Why?
CD4-Positive T-Lymphocytes
1
2017
1138
0.080
 Why?
Fibronectins
1
2011
136
0.080
 Why?
Bronchoscopy
1
2011
227
0.080
 Why?
Collagen Type I
1
2011
143
0.080
 Why?
Proto-Oncogene Proteins
1
2013
623
0.080
 Why?
Asthma
1
2022
1795
0.080
 Why?
Survival Rate
4
2013
2087
0.080
 Why?
Protein Inhibitors of Activated STAT
1
2009
6
0.080
 Why?
Cellular Senescence
1
2012
226
0.080
 Why?
Cadherins
1
2011
200
0.070
 Why?
Vena Cava, Superior
1
2009
25
0.070
 Why?
Pulmonary Alveoli
1
2012
385
0.070
 Why?
Coronary Vessel Anomalies
1
2009
38
0.070
 Why?
Transcriptional Activation
1
2011
372
0.070
 Why?
Interleukin-1beta
1
2011
390
0.070
 Why?
Delivery of Health Care
1
2016
946
0.070
 Why?
Disease Models, Animal
2
2011
4552
0.070
 Why?
Global Health
1
2011
403
0.070
 Why?
Dibenzocycloheptenes
1
2008
5
0.070
 Why?
Colorimetry
1
2008
12
0.070
 Why?
Oncogene Protein v-akt
1
2008
23
0.070
 Why?
Prospective Studies
4
2025
8035
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2008
72
0.070
 Why?
Antigens, CD
1
2011
558
0.070
 Why?
Indicators and Reagents
1
2008
106
0.070
 Why?
Molecular Chaperones
1
2009
199
0.070
 Why?
Occupational Exposure
1
2011
355
0.070
 Why?
Abnormalities, Multiple
1
2009
197
0.070
 Why?
Antimetabolites, Antineoplastic
1
2008
105
0.070
 Why?
Mesothelioma
1
2008
51
0.070
 Why?
Electronic Health Records
1
2016
1188
0.060
 Why?
Pulmonary Disease, Chronic Obstructive
2
2012
919
0.060
 Why?
Respiration, Artificial
1
2012
713
0.060
 Why?
Azacitidine
1
2008
157
0.060
 Why?
Comorbidity
1
2011
1657
0.060
 Why?
DNA, Complementary
1
2006
273
0.060
 Why?
Contrast Media
1
2009
497
0.060
 Why?
Nitrates
1
2006
93
0.060
 Why?
Randomized Controlled Trials as Topic
1
2012
1742
0.060
 Why?
Gene Expression Regulation, Neoplastic
3
2009
1442
0.060
 Why?
Lymphatic Metastasis
2
2003
331
0.060
 Why?
Oxidative Stress
1
2012
1351
0.060
 Why?
Mice, Inbred C57BL
2
2007
5972
0.060
 Why?
Biomarkers
2
2017
4282
0.050
 Why?
Collagen
1
2007
455
0.050
 Why?
Case-Control Studies
1
2012
3616
0.050
 Why?
Organ Culture Techniques
1
2004
154
0.050
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
1958
0.050
 Why?
Pruritus
1
2024
59
0.050
 Why?
Survival Analysis
2
2005
1371
0.050
 Why?
Inhibitory Concentration 50
1
2004
90
0.050
 Why?
Adult
7
2024
40665
0.050
 Why?
Flavonoids
1
2004
85
0.050
 Why?
Flow Cytometry
1
2008
1159
0.050
 Why?
Eczema
1
2024
66
0.050
 Why?
Apoptosis
2
2013
2434
0.050
 Why?
Exanthema
1
2024
86
0.050
 Why?
Biopsy, Fine-Needle
1
2003
68
0.050
 Why?
Protein Processing, Post-Translational
1
2006
469
0.050
 Why?
Kinetics
1
2006
1567
0.050
 Why?
Psoriasis
1
2024
115
0.050
 Why?
Drug Combinations
1
2004
396
0.050
 Why?
Base Sequence
1
2006
2168
0.050
 Why?
DNA Methylation
1
2008
667
0.050
 Why?
Predictive Value of Tests
3
2005
2115
0.050
 Why?
Janus Kinase 3
1
2002
19
0.050
 Why?
STAT6 Transcription Factor
1
2002
24
0.050
 Why?
Janus Kinase 1
1
2002
26
0.050
 Why?
Histoplasmosis
1
2002
15
0.050
 Why?
Iowa
1
2002
31
0.050
 Why?
STAT5 Transcription Factor
1
2002
50
0.050
 Why?
Lymph Nodes
2
2002
502
0.050
 Why?
Endosonography
1
2003
160
0.050
 Why?
Carcinoembryonic Antigen
1
2002
40
0.040
 Why?
Antineoplastic Agents
2
2005
2207
0.040
 Why?
Cell Polarity
1
2003
137
0.040
 Why?
Genes, p53
1
2002
67
0.040
 Why?
Tyrosine
1
2002
217
0.040
 Why?
Biopsy
3
2016
1079
0.040
 Why?
Heart Defects, Congenital
1
2009
904
0.040
 Why?
Neoplasm Metastasis
1
2003
688
0.040
 Why?
Protein Transport
1
2002
441
0.040
 Why?
Inflammation
1
2012
2876
0.040
 Why?
Steroids
1
2021
160
0.040
 Why?
Fatigue
1
2022
363
0.040
 Why?
United States
2
2022
16065
0.040
 Why?
Mice, Transgenic
1
2005
2185
0.040
 Why?
Biomarkers, Tumor
1
2006
1320
0.040
 Why?
Skin
1
2024
753
0.040
 Why?
Cell Nucleus
1
2002
587
0.040
 Why?
Drug Resistance, Neoplasm
3
2014
881
0.040
 Why?
Immunologic Factors
1
2021
260
0.040
 Why?
Diagnosis, Differential
1
2002
1506
0.030
 Why?
DNA
1
2004
1433
0.030
 Why?
Lymphocyte Count
1
2017
163
0.030
 Why?
Sensitivity and Specificity
1
2002
1995
0.030
 Why?
Antigen-Presenting Cells
1
2017
159
0.030
 Why?
Retrospective Studies
1
2015
17247
0.030
 Why?
Immunophenotyping
1
2017
318
0.030
 Why?
Follow-Up Studies
1
2025
5411
0.030
 Why?
Disease Progression
2
2016
2857
0.030
 Why?
Prevalence
1
2002
2855
0.030
 Why?
Immunoenzyme Techniques
1
2013
200
0.020
 Why?
Lymphocyte Activation
1
2017
1131
0.020
 Why?
Aniline Compounds
1
2014
120
0.020
 Why?
Tumor Microenvironment
1
2017
733
0.020
 Why?
Nitriles
1
2014
207
0.020
 Why?
Real-Time Polymerase Chain Reaction
1
2013
337
0.020
 Why?
Quinolines
1
2014
190
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
1
2013
254
0.020
 Why?
Protein Kinases
1
2014
312
0.020
 Why?
Mice, Nude
1
2013
679
0.020
 Why?
Sequence Analysis, RNA
1
2014
442
0.020
 Why?
Pregnancy
1
2004
7182
0.020
 Why?
Chronic Disease
1
2016
1806
0.020
 Why?
Immunoprecipitation
1
2009
148
0.020
 Why?
Electrophoretic Mobility Shift Assay
1
2009
88
0.020
 Why?
Computational Biology
1
2014
669
0.020
 Why?
Communication
1
2016
973
0.020
 Why?
Immunohistochemistry
2
2003
1713
0.020
 Why?
Angiography
1
2009
208
0.020
 Why?
Fatal Outcome
1
2009
305
0.020
 Why?
Plasmids
1
2009
373
0.020
 Why?
Cyclin-Dependent Kinase 4
1
2007
53
0.020
 Why?
Registries
1
2016
2401
0.020
 Why?
Up-Regulation
1
2009
846
0.020
 Why?
Structure-Activity Relationship
1
2007
563
0.010
 Why?
Echocardiography
1
2009
647
0.010
 Why?
Mediastinoscopy
1
2005
5
0.010
 Why?
Polymerase Chain Reaction
1
2008
1039
0.010
 Why?
Trastuzumab
1
2005
118
0.010
 Why?
Kaplan-Meier Estimate
1
2006
968
0.010
 Why?
Electric Conductivity
1
2003
85
0.010
 Why?
Multivariate Analysis
1
2006
1546
0.010
 Why?
Transcription, Genetic
1
2009
1454
0.010
 Why?
Infant
1
2016
10060
0.010
 Why?
Hypoxia
1
2009
1197
0.010
 Why?
Immunoassay
1
2002
109
0.010
 Why?
Trachea
1
2003
258
0.010
 Why?
Ligands
1
2003
664
0.010
 Why?
Risk Assessment
1
2009
3740
0.010
 Why?
Antibodies, Monoclonal, Humanized
1
2005
992
0.010
 Why?
Rats, Sprague-Dawley
1
2003
2524
0.010
 Why?
Calcium
1
2003
1189
0.010
 Why?
Wounds and Injuries
1
2003
960
0.010
 Why?
Rats
1
2003
5582
0.010
 Why?
Kern's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (293) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)